Skip to Main Content

Paper Details

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.
Nat Commun
24
2020
ER, G-alpha, GTPases, Rho, breast cancer, cancer, estrogen, estrogen receptor, estrogen receptor (ER)-negative, gene modules, germline, germline variants, patients
Author NameAffiliation
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Irene L AndrulisFred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
Irene L AndrulisUniversity of Toronto
Hoda Anton-CulverGenetic Epidemiology Research Institute, University of California Irvine
Hoda Anton-CulverGenetic Epidemiology Research Institute, University of California Irvine
Alan AshworthUCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco
Paul L AuerFred Hutchinson Cancer Research Center
Paul L AuerZilber School of Public Health, University of Wisconsin-Milwaukee
Jonathan BeesleyQIMR Berghofer Medical Research Institute
Jonathan BeesleyQIMR Berghofer Medical Research Institute
Sabine BehrensGerman Cancer Research Center (DKFZ)
Javier Ben??tezSpanish National Cancer Research Centre (CNIO)
Javier Ben??tez
William J BlotVanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
William J BlotInternational Epidemiology Institute
Anne-Lise B??rresen-DaleInstitute for Cancer Research, Oslo University Hospital-Radiumhospitalet
Anne-Lise B??rresen-DaleUniversity of Oslo
Anne-Lise B??rresen-DaleInstitute for Cancer Research, Oslo University Hospital-Radiumhospitalet
Anne-Lise B??rresen-DaleUniversity of Oslo
Carlos CaldasCancer Research UK Cambridge Institute, University of Cambridge
Carlos CaldasCRUK Cambridge Cancer Centre and NIHR Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust
Federico CanzianGerman Cancer Research Center (DKFZ)
Jenny Chang-ClaudeGerman Cancer Research Center (DKFZ)
Jenny Chang-ClaudeUniversity Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Christine L ClarkeWestmead Institute for Medical Research, University of Sydney
Christine L ClarkeWestmead Institute for Medical Research, University of Sydney
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Janet A DunnWarwick Clinical Trials Unit, University of Warwick
Alison M DunningUniversity of Cambridge
Michael R StrattonUniversity of Southampton
Peter A FaschingComprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg
Peter A FaschingDavid Geffen School of Medicine, University of California at Los Angeles
Jonine D FigueroaNational Cancer Institute, National Institutes of Health
Jonine D Figueroa
Jonine D FigueroaThe University of Edinburgh Medical School
Jonine D FigueroaNational Cancer Institute, National Institutes of Health
Jonine D FigueroaThe University of Edinburgh Medical School
Jonine D Figueroa
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Montserrat Garcia-ClosasInstitute of Cancer Research
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Montserrat Garcia-ClosasInstitute of Cancer Research
Mia M Gaudet
Graham G Giles
Graham G GilesMonash University
Graham G GilesThe University of Melbourne
  • 1 - 50

Datasets